The regulations elaborate a set of recurring administrative and clinical concepts that link back to the Act and to other statutes. Core concepts are:

• Report to support an application (reg 4). An application to the Tribunal under the Act (other than a s 58 request) must be supported by a report from a health practitioner or other person with relevant qualifications and expertise to assess decision-making ability. The report must detail the impairment in accordance with Part 2 of the Act and state whether the impairment affects capacity in personal and/or financial matters (reg 4(1)(a)-(b)). For s 44 applications the form and content of the report are prescribed in detail (reg 4(3)). If a report cannot be provided, a statement of reasons must be supplied (reg 4(5)). A person who assesses decision-making ability must not submit a report about a close family member (reg 4(6)).

• Declaration supporting applications (reg 5). Every application must be supported by a declarant’s statement that reasonable steps to comply with s 13 of the Act have been taken, that information in the application is true and accurate, not misleading, and not omitting relevant details (reg 5(1)). Making an application that is false or materially misleading is a penalised act (reg 5(2)).

• Special treatment and treatment thresholds (regs 11-13). The regulations declare psychosurgery (and specified neurological procedures) and treatments involving aversive stimuli as “special treatment” for Part 6 (reg 11). Regulation 12 lists the types of medical or dental treatment that cannot be undertaken without the consent regime in Division 2 of Part 6: continuing administration of a restricted substance primarily to control conduct, administration of drugs of addiction save for cancer/palliative contexts, electroconvulsive therapy, treatments carrying substantial risks to life or major functions, and treatments likely to remove all or many teeth (reg 12). Oral consents given by a responsible person must be confirmed in writing as soon as practicable (reg 13).

• Advance care directives and associated process rules (Part 3A: regs 13A-13D, 13AB). The Part adopts the Act’s definition of “health care” for the Part (reg 13A). Speech pathologists are prescribed as health practitioners for purposes of Part 5A (reg 13AB). “Mandatory health care” is defined to include health care required under a direction from the Director of Public Health under s 42 of the Public Health Act 1997 (reg 13B). The rules set out who may apply to register an advance care directive (the maker, legal representative, adult on behalf if requested by the person, guardian with health care authority, person responsible, or any person the Tribunal is satisfied has a proper interest) and that the application must be in a Tribunal‑approved form and include the written original directive (reg 13C). Revocation of an advance care directive is by written indication if the directive was written, or either by the same method it was given or by written indication if it was given otherwise (reg 13D).

• Complaints process standard (reg 13E). The Public Guardian and Public Trustee must ensure complaints processes are consistent with Australian Standard 10002 Guidelines for complaint management in organisations (ISO 10002:2018 NEQ) (reg 13E).

• Fees (regs 14-15 and Schedule 1). Schedule 1 lists fee unit amounts for registration, search, copies and recordings under the Act. Regulation 15 imposes a specified fee for the Tribunal to examine statements of accounts for a “relevant estate” (estate value > $50,000) and sets different charges depending on whether the administrator is the Public Trustee or a trustee company (83.5 fee units) or a different administrator (118 fee units) (reg 15(2)). Certain asset classes are excluded from estate valuation for this purpose (reg 15(3)). A registrar may waive fees on grounds of undue hardship (reg 16).

• Inspection of Tribunal register (reg 17). The register is open for public inspection during business hours generally, but access to an advance care directive registered with the Tribunal is limited to the directive maker, relevant guardians, the person responsible, treating health practitioners and facilities, and any other person the Tribunal is satisfied has a proper interest (reg 17(2)-(3)).

These concepts establish documentary and evidentiary thresholds for Tribunal processes, identify specific clinical categories that trigger higher threshold decision-making under the Act, and create a fee and access framework that allocates costs and access rights.

The regulations affect a defined set of public and private actors who participate in the guardianship, health-care consent and administration ecosystem.

• Applicants to the Tribunal. Any person applying to the Tribunal under the Act is directly affected by reg 4 and reg 5. Applicants must produce or arrange for supporting assessment reports (except for s 58 requests, see reg 4(2)), make the statutory declaration prescribed by reg 5, and ensure applications are not materially false or misleading (reg 5(1)-(2)). Applicants who fail to provide a report must supply a statement explaining why (reg 4(5)).

• Health practitioners and assessment practitioners. Registered health practitioners and other persons with relevant qualifications are required to prepare assessment reports that meet the content requirements in reg 4. Where an application is for s 44 purposes (treatment authorisation), reg 4(3) lists detailed clinical items that a registered health practitioner must include. Speech pathologists are expressly prescribed as health practitioners for Part 5A operations (reg 13AB). The regulations also prohibit assessors from producing reports about close family members (reg 4(6)). Health practitioners providing treatment must also note the limits on treating without consent for treatments listed in reg 12, and ensure oral consents provided under s 43 are followed by written confirmation (reg 13).

• Guardians and the person responsible. Guardians with health-care authority, persons responsible under the Act and enduring guardians are affected by the registration and revocation rules for advance care directives (regs 13C-13D), by the requirement to confirm oral consents in writing if they give consent (reg 13), and by the public register access rules (reg 17). A guardian for a person who gave an advance care directive may register that directive only if they have health decision authority (reg 13C(1)(d)).

• Administrators of represented persons’ estates. Administrators who lodge statements of accounts for estates valued over $50,000 (a “relevant estate”) must pay the Tribunal’s examination fee prescribed in reg 15(2). Different fee rates apply depending on whether the administrator is the Public Trustee or a trustee company, or another person (reg 15(2)). Administrators must account for asset exclusions specified in reg 15(3) when calculating estate value.

• The Public Trustee and trustee companies. The Public Trustee and trustee companies are both subject to the fee regimes (Schedule 1; reg 15(2)(a) sets a lower fee if the administrator is the Public Trustee or a trustee company). They are also subject to the complaints-process standard in reg 13E.

• The Public Guardian. The Public Guardian must ensure complaints processes are ISO‑10002‑consistent (reg 13E). The Public Guardian is also likely to be engaged in functions under the Act that the regulations support.

• Hospitals, hospices and health facilities. These entities are specifically listed as persons with access to registered advance care directives (reg 17(3)(e)). Clinical staff in those settings are affected by reg 12’s list of treatments that cannot be undertaken without compliance with the Act’s consent regime.

• The Tribunal and its registrars. The Tribunal is the decision-maker; the regulations set what documents must be provided to the Tribunal and the fees payable for Tribunal services (regs 4, 5, 14-15). A registrar has discretion to waive fees on grounds of undue hardship (reg 16). The Tribunal also controls the register and may be asked to be satisfied that a person has a proper interest when permitting access to a registered advance care directive (reg 17(3)(f), reg 13C(1)(f)).

• Members of the public and persons with a proper interest. The register is generally open for public inspection (reg 17(2)), but access to advance care directives is limited to specified interested persons and providers (reg 17(3)). Individuals with “a proper interest” may apply to register or inspect directives subject to Tribunal satisfaction (reg 13C(1)(f); reg 17(3)(f)).

Indirect effects relate to estate planning practitioners, lawyers preparing enduring guardianship instruments (Schedule 1 fees for registration and copy services), and clinical teams who must align procedural documentation with the Tribunal’s evidentiary expectations when applications are contemplated. The regulations also bring in provisions from other statutes (see next section), so actors regulated under the Poisons Act 1971, Public Health Act 1997 and the Trustee Companies Act 1953 are implicated as well.

The regulations create explicit duties to prepare, lodge and confirm documents, and lay down accompanying rights concerning inspection, waiver and registration.

Duties

• Produce assessment reports for Tribunal applications. For most applications to the Tribunal under the Act, the applicant must supply a report from a health practitioner or other suitably qualified person that (a) details the impairment to decision-making ability in accordance with Part 2 of the Act, (b) states whether that impairment affects personal and/or financial decision-making, and (c) provides details of reasonable steps taken to support the person to make or communicate decisions (reg 4(1)(a)-(c)). If the report cannot be provided, the applicant must include a statement of reasons (reg 4(5)). For s 44 applications the report must be from a registered health practitioner and include the prescribed clinical particulars (reg 4(3)(a)-(k)).

• Avoid conflicts of interest in reporting. A person conducting an assessment must not submit a report assessing the decision-making ability of a close family member (reg 4(6)). This is a duty with a specified penalty: fine not exceeding 10 penalty units.

• Make statutory declarations with applications. Every application must be supported by a declaration that reasonable steps have been taken to comply with s 13 of the Act, and that the application is true, accurate, not misleading and not omitting relevant details (reg 5(1)). Making an application that is false or misleading in a material particular is penalised (reg 5(2)), with the penalty capped at 10 penalty units.

• Confirm oral consent in writing. A responsible person who gives oral consent under s 43 must provide written confirmation as soon as practicable to the person to whom consent was given (reg 13).

• Pay specified fees. Fees set out in Schedule 1 are payable for the listed services and registrations (reg 14). An administrator of a relevant estate must pay the prescribed fee for the Tribunal to examine the statement of accounts (reg 15(2)). Administrators must exclude certain items (principal residence, household furniture etc.) when calculating the value of the estate for the “relevant estate” threshold (reg 15(3)).

• Use Tribunal forms and originals for advance care directive registration. Applications to register an advance care directive must be in a form approved by the Tribunal and must include the written original (reg 13C(2)(a)-(b)). The list of applicants who may register is defined tightly (reg 13C(1)).

• Follow complaints-process standard. The Public Guardian and Public Trustee must ensure their complaints processes are consistent with Australian Standard 10002 (ISO 10002:2018 NEQ) (reg 13E).

Rights and administrative powers

• Right of limited public inspection. The register is to be made available for inspection during normal business hours (reg 17(2)). However, access to advance care directives is restricted to specified persons and providers, or other persons the Tribunal considers to have a proper interest (reg 17(3)).

• Power to waive fees. A registrar may waive all or part of a fee on application if satisfied that payment would cause undue hardship to the person or a person represented by the person (reg 16). This creates administrative discretion to relieve financial burden.

• Fee schedule and differing rates. Schedule 1 specifies monetary (fee unit) entitlements for registration, searches, copy and certified copy services, and a lower fee for Public Trustee or trustee-company administrators in reg 15(2)(a).

• Right to revoke and prescribed revocation methods. A maker of an advance care directive has a right to revoke. For written directives, revocation must be by a written indication (reg 13D(1)). For directives given other than in writing, revocation may be by the same method used to make the directive, or by written indication (reg 13D(2)(a)-(b)).

Duty interplay with other statutes

• Definitions and cross-references. Several duties depend on definitions or powers in other statutes. The meaning of “restricted substance” and “drug of addiction” is taken from the Poisons List under the Poisons Act 1971 (reg 3). “Mandatory health care” is defined to include public health directions under s 42 of the Public Health Act 1997 (reg 13B). The meaning of “trustee company” is from the Trustee Companies Act 1953 (reg 15(2)(a)). Registrar functions and waiver powers operate within the framework of the Tasmanian Civil and Administrative Tribunal Act 2020 (reg 16).

Sanctions and enforcement mechanisms

• Monetary penalties for false/misleading applications and prohibited reporting (reg 4(6), reg 5(2)): fine not exceeding 10 penalty units. Fee non-payment consequences are not specified in these regulations, but the fee schedule in Schedule 1 and the obligation in reg 15 mean that administrators must budget to meet Tribunal fees when filing accounts.

The regulations therefore create a largely documentary and fee-based compliance regime that assigns responsibilities to applicants, health practitioners, administrators and Tribunal officers, while giving the Tribunal and its registrars limited discretionary relief powers.

The regulations attach direct monetary penalties for specific contraventions and create fee‑based obligations that are enforceable through payment requirements. The principal enforcement features in the text are as follows.

Specified penalties

• Reporting about a close family member. Regulation 4(6) provides a direct penal sanction: a health practitioner or other qualified person must not submit a report that deals with the decision-making ability of a close family member of the person. The breach attracts a penalty of a fine not exceeding 10 penalty units.

• False or materially misleading applications. Regulation 5(2) makes it an offence to make an application under the Act that is false or misleading in a material particular. That offence also carries a penalty of a fine not exceeding 10 penalty units.

The regulations do not specify alternative penalties such as suspension, disqualification or administrative fines beyond those two penal provisions. Nor do they in this text specify what procedural consequence follows a failure to provide a supporting report beyond the requirement to supply a statement of reasons (reg 4(5)).

Fees as an enforcement and cost-allocation mechanism

• Schedule 1. The Schedule sets the fees payable for a number of routine Tribunal and registry services, expressed in fee units (reg 14 plus Schedule 1). Items include registration of enduring guardianship instruments (45 fee units), registration of revoking instruments (32 fee units), searches and inspections (19.5 fee units), copies and certified copies, and charges for recordings and photocopies.

• Examination fee for statements of accounts. Regulation 15(2) requires that on providing to the Tribunal a statement of accounts for a “relevant estate” (estate worth more than $50,000 at the valuation date), the administrator must pay a fee for the Tribunal to examine the statement: 83.5 fee units if the administrator is the Public Trustee or a trustee company, 118 fee units if the administrator is not the Public Trustee or a trustee company. The regulation ties the Tribunal’s examination function to a payment obligation. Regulation 15(3) clarifies certain asset classes are excluded when determining whether an estate is a relevant estate.

• Registrar waiver power. Regulation 16 grants discretionary relief: on application, a registrar may waive all or part of a fee if satisfied that payment would cause undue hardship to the person or a person represented by the person. This creates a pathway to avoid payment obligations in hardship cases, subject to registrar satisfaction.

Enforcement architecture and authorities

• Tribunal and registrar roles. The regulations are designed to be administered through the Tribunal and its registrars for intake, registration and examination tasks. The text does not explicitly set out enforcement processes such as late payment penalties or enforcement pathways for unpaid fees; those procedural matters may be governed by the Tribunal’s practice directions or other statutes, not reproduced here.

• Administrative oversight. The regulations state they are administered by the Department of Justice, which places administrative responsibility with an executive agency. The complaints-process standard in reg 13E imposes an internal complaints governance obligation on the Public Guardian and Public Trustee (consistency with ISO 10002).

Limitations and interpretive cautions

• Value of a penalty unit. The regulations cite fines in terms of “penalty units” without stating the dollar equivalent. The monetary value of a penalty unit can change over time under other enactments or Treasury determinations. The exact dollar cost of the fines in reg 4(6) and reg 5(2) therefore depends on current penalty unit valuation, not provided here.

• No explicit criminal enforcement details. The regulations set out the offences and fees but do not explain prosecutorial, enforcement or collection mechanisms in this instrument. Those procedures would be governed by the Act itself or by general procedural statutes.

In summary, enforcement in the regulations is a mix of penal sanctions (two specific offences capped at 10 penalty units each) and administrative, fee-based obligations that the Tribunal enforces in its registry activities, with a registrar waiver available on hardship grounds.

The regulations are explicitly cross-referential and rely on definitions and powers established in multiple statutes and standards. The key interplays are as follows:

• Guardianship and Administration Act 1995 (the Act). The regulations are designed to implement and operationalise particular parts of the Act. They reference numerous sections of the Act, including s 13 (reasonable steps), s 32-33 (registration of enduring guardianship instruments), s 35E (definition of health care), s 35L (mandatory health care), s 35X (registering advance care directives), s 35Y (revocation), s 41(2) (treatment without consent), s 43 (consent by person responsible), s 44 (treatment applications), s 48O (Part 6A matters), s 58 (requests excluded from reg 4(1)), s 63 (statements of accounts), s 70(3) (complaints processes) and s 89 (register) (see reg 4, reg 5, regs 11-13D, reg 13E, regs 14-17).

• Poisons Act 1971 and Poisons List. Regulation 3 imports the Poisons List concepts: “drug of addiction” means a substance listed in Schedule 8 to the Poisons List, “Poisons List” has the same meaning as in the Poisons Act 1971, and “restricted substance” means a substance listed in Schedule 4 to the Poisons List. These definitions are used in reg 12 to determine which treatments cannot be provided without the consent regime being followed (e.g. continuing administration of restricted substances to control conduct, administration of drugs of addiction outside cancer/palliative care contexts).

• Public Health Act 1997. Regulation 13B explicitly incorporates the Director of Public Health’s direction-making power under s 42 of the Public Health Act 1997 into the definition of “mandatory health care” for the Act’s Part 5A. In practice this means public health directions can trigger the “mandatory health care” concept under the Guardianship regime.

• Trustee Companies Act 1953. Regulation 15(2)(a) uses the meaning of trustee company within the Trustee Companies Act 1953 to determine which administrators pay the lower Tribunal examination fee.

• Tasmanian Civil and Administrative Tribunal Act 2020. Regulation 16 vests power in a “registrar, within the meaning of the Tasmanian Civil and Administrative Tribunal Act 2020” to waive fees for undue hardship, linking fee waiver power to the Tribunal’s enabling statute and its office holders.

• Australian Standards / ISO. Regulation 13E requires the Public Guardian and Public Trustee complaints processes be consistent with Australian Standard 10002 Guidelines for complaint management in organisations (ISO 10002:2018 NEQ), incorporating an external administrative standard into governance requirements.

• Rules Publication Act 1953. The Schedule states the fee schedule is displayed and numbered in accordance with the Rules Publication Act 1953, indicating the publication and notification framework in which subordinate instruments must be presented.

Operational implications of these interactions

• Definitions and thresholds are sourced externally. What counts as a restricted substance or drug of addiction depends entirely on the Poisons List under the Poisons Act 1971; any subsequent changes to that list will change how reg 12 operates. Similarly, the value of a penalty unit and treatment directions under public health law will affect the application of these regulations without further change to these regulations themselves.

• Cross-agency coordination. The incorporation of public health directions, trustee-company status and ISO standards requires coordination between health, trustee, tribunal and justice agencies to ensure consistent application and interpretation.

• Administrative delegation and discretion. The registrar waiver power operates within the Tribunal statutory framework, so Tribunal practice and procedural rules under the Tasmanian Civil and Administrative Tribunal Act will influence how waiver is administered.

• Standards-driven internal governance. The requirement that complaints-handling conform to ISO 10002 imposes a process and record-keeping obligation on the Public Guardian and Public Trustee that may interact with their broader statutory duties under the Act and other administrative law obligations.

• Evidence-based application intake. The regulations turn to professional reports and signed statutory declarations as gateway requirements to Tribunal jurisdiction in many applications, importing clinical, forensic and evidential standards from the health and legal professions into the Tribunal’s intake process.

In short, the regulations depend on and operate with multiple other statutes and a standards regime, so changes in those other instruments (Poisons List updates, public health directions, trustee definitions, Tribunal practice rules, or penalty unit values) will materially change how these regulations function.

The regulations record multiple post-enactment changes, and the text annotates the affected provisions with the statutory instruments and applied dates. The principal amendments reflected in the text are:

• Initial commencement and notification. The regulations took effect on 17 October 2017 and were notified in the Gazette on that date (reg 2; footer note).

• 2021 amendments (No. 18 of 2021). Several provisions were amended with an applied date of 05 November 2021:

  • Regulation 15 subregulation (2) was amended by No. 18 of 2021, s. 172, Applied: 05 Nov 2021 (reg 15(2) amendment annotation).
  • Regulation 16 was amended by No. 18 of 2021, s. 173, Applied: 05 Nov 2021 (reg 16 annotation).
  • Schedule 1 was amended by No. 18 of 2021, s. 174, Applied: 05 Nov 2021 (Schedule 1 amendment note).

• 2022 amendments (S.R. 2022, No. 88). Multiple insertions were made and applied 21 November 2022:

  • Regulation 13A (Interpretation of Part 3A , health care definition) was inserted by S.R. 2022, No. 88, Applied: 21 Nov 2022.
  • Regulation 13B (Mandatory health care) was inserted by S.R. 2022, No. 88, Applied: 21 Nov 2022.
  • Regulation 13C (Application to register advance care directive) was inserted by S.R. 2022, No. 88, Applied: 21 Nov 2022.
  • Regulation 13D (Revocation of advance care directive) was inserted by S.R. 2022, No. 88, Applied: 21 Nov 2022.
  • Regulation 17 (Inspection of register) was inserted by S.R. 2022, No. 88, Applied: 21 Nov 2022.
  • The insertion of these Part 3A provisions indicates a post-2017 policy development to codify advance care directive processes.

• 2024 amendments (S.R. 2024, No. 39). A substantial consolidation and substitution occurred, applied 01 September 2024:

  • Part 2 (Applications under the Act) was substituted by S.R. 2024, No. 39, Applied: 01 Sep 2024, and Division 1 of Part 2 was rescinded by the same instrument (reg annotations for Part 2).
  • Regulation 3 (Interpretation) was amended by S.R. 2024, No. 39, Applied: 01 Sep 2024 (annotations showing Poisons List import).
  • Regulation 4 (Application to be supported by report) was substituted by S.R. 2024, No. 39, Applied: 01 Sep 2024.
  • Regulation 5 (Application to be supported by declaration) was substituted by S.R. 2024, No. 39, Applied: 01 Sep 2024.
  • Several regulations were rescinded: Regulations 6, 7, 8, 9 and 10 were rescinded by S.R. 2024, No. 39, Applied: 01 Sep 2024.
  • Regulation 13AB (Speech pathologists prescribed as health practitioners) was inserted by S.R. 2024, No. 39, Applied: 01 Sep 2024.
  • Regulation 13E (Complaints processes) was inserted by S.R. 2024, No. 39, Applied: 01 Sep 2024.
  • Regulation 15 subregulation (1) was amended by S.R. 2024, No. 39, Applied: 01 Sep 2024 (annotation on reg 15(1)).

• Other annotated amendments. Some provisions show multiple amendment annotations (for example reg 4 and reg 5 note substitution by S.R. 2024 No. 39; reg 15 shows a 2021 amendment and a 2024 amendment). Schedule 1 shows amendment by No. 18 of 2021.

What the amendment annotations indicate about the instrument

• The regulations have been actively maintained. The 2022 and 2024 insertions and substitutions show evolving policy focus, including the creation and operationalisation of advance care directive registration (2022 insertions) and a broad redraft or consolidation of application rules in 2024.

• Substantial rework in 2024. The substitution of Part 2 and the rescission of multiple regulations suggest procedural streamlining or reallocation of responsibilities in the application intake framework. The detailed effect of the substitution is visible in the content of the substituted regs 4 and 5 in the provided text.

• Fee schedule adjustments in 2021. The 2021 amendments to reg 15 and Schedule 1 changed the financial structure of Tribunal fees and the fee charged to administrators examining estate accounts. The text shows different fee unit amounts and the introduction of the “relevant estate” threshold definition in reg 15(1).

For precise legislative history beyond these annotations, practitioners should consult the consolidated version of the Regulations and the specific Statutory Rules cited: S.R. 2022, No. 88; No. 18 of 2021; and S.R. 2024, No. 39, all with their applied dates as annotated in the text.

The regulations as presented do not record any cases or judicial decisions that interpret them. The text contains no reference to litigation, court rulings, Tribunal decisions or statutory appeals. The only adjudicative body named in the instrument is the Tribunal itself (the Tasmanian Civil and Administrative Tribunal), which is the forum for applications under the Act; however, the instrument does not cite or summarise any cases decided under the Act or these regulations.

Practical consequences for a researcher or litigator

• No cases in the instrument. Because the regulations do not contain a litigation history, anyone researching the legal interpretation or contested applications must consult Tribunal decisions and superior court judgments separately. These decisions will not be found in the regulations; only the operative rules and fee schedules are recorded here.

• Issues likely to be litigated. Although the regulations do not indicate past litigation, the text sets out points that are common loci of dispute and may therefore have produced Tribunal or court cases in practice, such as:

  • Whether a report meets the content and quality requirements of reg 4, including adequate detail about impairment and reasonable support steps.
  • Whether a person seeking to register or access an advance care directive has a “proper interest” for the Tribunal’s purposes (regs 13C(1)(f) and 17(3)(f)), a concept susceptible to factual and legal contest.
  • The scope of treatments that require consent under reg 12, e.g. what counts as administration of a drug of addiction “other than in association with the treatment of cancer or palliative care”.
  • Disputes arising from fee waivers or fee assessments, particularly under reg 15’s different fee rates and reg 16’s waiver discretion.

• Where to find decisions. To trace litigation that interprets these regulations you must search Tribunal decisions and Tasmanian court databases for cases mentioning the sections of the Act that the regulations implement, or decisions referencing these specific regulation numbers. The regulations themselves do not supply a case list.

If you require a systematic search strategy for Tribunal or court decisions that have engaged these regulations (for example, cases on registration of advance care directives, disputes over Part 6 treatment authorisations, or contested account examinations under reg 15), indicate the specific subject area and I will propose a targeted research plan for locating relevant decisions.

Several specific features of the regulations create practical pitfalls that practitioners, clinicians and administrators should note. These are concrete requirement mismatches, narrow drafting points and discretionary mechanisms that commonly cause compliance failures or disputes.

• Close family reporting prohibition (reg 4(6)). A health practitioner or other qualified assessor must not submit a report that deals with the decision-making ability of a close family member of the person. This is an absolute prescriptive prohibition with a penalty (fine not exceeding 10 penalty units). A common pitfall is allowing clinicians with close familial relationships to produce reports in good faith; the regulation prohibits that and the penalty attaches.

• Narrow exclusions and application exceptions (reg 4(2), reg 13C(1)(c)). Regulation 4(2) states that subregulation (1) does not apply to a request under s 58 of the Act. Practitioners must not assume all Tribunal applications require the same report format; the s 58 exception means different documentary gateways may apply and you must check the Act. Regulation 13C(1)(c) allows an adult to apply to register an advance care directive only if the registration is requested by the person who gave the directive. That prevents third-party registration absent an explicit request from the maker.

• Prescribed content requirements for s 44 reports (reg 4(3)(a)-(k)). For applications under s 44 the report must be from a registered health practitioner and include specified items such as the condition requiring treatment, the nature and timing of proposed treatment, impairment to decision-making, risks of treatment and non-treatment, whether the person is likely to become capable of consent, and alternatives. Failure to include any of these prescribed items may render the application defective or incomplete. Clinicians preparing s 44 reports must therefore follow the list closely.

• Treatment categories that require consent processes (reg 12). The regulation identifies specific treatments that may not be carried out without consent under Division 2 of Part 6: continuing administration of a restricted substance primarily to control conduct; administration of drugs of addiction except in cancer or palliative care; ECT; treatments carrying substantial risk of death, brain damage, paralysis, permanent organ/limb loss, permanent and disfiguring scarring, extreme pain; and treatments intended to remove all or a substantial number of teeth. Clinical teams and responsible persons must be alert to these categories before commencing treatment, because the regulation elevates their procedural thresholds.

• Oral consent must be followed by written confirmation (reg 13). A responsible person who gives oral consent under s 43 must provide written confirmation “as soon as practicable” to the person to whom consent was given. Failure to document oral consents promptly creates a compliance risk.

• Fee unit amounts and conversion. Fees are expressed in “fee units” in Schedule 1 and reg 15. The regulations do not give the dollar value of a “fee unit.” Practitioners must check the current statutory valuation of a fee or penalty unit in Tasmania at the relevant date to calculate actual dollar obligations. Do not assume fee unit amounts are static.

• Different fee rates for statement examination (reg 15(2)). If an administrator of a “relevant estate” provides accounts, the fee for examination is 83.5 fee units if the administrator is the Public Trustee or a trustee company, but 118 fee units if the administrator is not. This differential rate can materially affect which administrators choose to submit accounts and how they budget. It may also influence route selection by administrators (for example, whether to appoint a trustee company).

• Definition of “relevant estate” and excluded assets (reg 15(1)-(3)). The “relevant estate” threshold is assets over $50,000 at the last day of the accounting period. Several asset classes are excluded when valuing an estate for this purpose, including principal place of residence, household furniture and effects, certain deposits or bonds to residential aged care facilities, and the principal residence of a spouse or minor child. Misvaluing the estate by including excluded assets can trigger unjustified fee exposure.

• Register access restrictions for advance care directives (reg 17(3)). While the register is broadly available for public inspection (reg 17(2)), access to a registered advance care directive is narrowly limited to the maker, certain guardians, the person responsible, treating health practitioners and facilities, and any person the Tribunal is satisfied has a proper interest (reg 17(3)). Assuming full public access to directives is incorrect; access is controlled.

• Tribunal-approved form and original copy requirement for registration (reg 13C(2)). Applications to register an advance care directive must be in a Tribunal-approved form and must include the written original copy of the directive. Submitting a copy rather than an original, or failing to use the Tribunal form, risks refusal or delay.

• Discretionary waiver subjectivity (reg 16). A registrar may waive a fee if satisfied that payment would cause undue hardship. The terms “satisfied” and “undue hardship” invite subjective assessment; applications should be supported by documented financial evidence because waiver is discretionary and not automatic.

• Complaints process standard enforcement (reg 13E). The Public Guardian and Public Trustee must maintain complaints processes consistent with ISO 10002. Translating that requirement into operational policies, records, training and audit trails is an often-overlooked administrative obligation that may attract scrutiny in review or inquiry.

• Interdependence with external instruments. Several operational questions hinge on other instruments (Poisons List, Public Health directions, valuation of fee/penalty units). Changes to those external instruments will change how these regulations operate. Practitioners must monitor those instruments as well as the regulations.

These specific drafting and operational features create discrete compliance obligations and potential stumbling blocks for clinicians, Tribunal applicants and administrators. Each “gotcha” is grounded in the corresponding regulation citation set out above.

Below is a practical, step-by-step compliance map tied to the regulations’ operative provisions. It assumes you are acting for an applicant, a clinician preparing reports, an administrator of an estate, a guardian, or an institutional actor (hospital or trustee) engaging with the Tribunal.

Step 1: Determine whether the application requires a report (reg 4)

• Check the Act section under which you are applying. If the application is not a request under s 58 of the Act, you must provide a supporting report prepared by a health practitioner or other person with relevant qualifications and expertise to assess decision-making ability (reg 4(1); reg 4(2) carve-out for s 58).
• For general applications the report must detail the impairment to decision-making in accordance with Part 2 of the Act, indicate whether the impairment affects personal and/or financial matters, and state the reasonable steps taken to provide practicable and appropriate support to enable decision-making or communication (reg 4(1)(a)-(c)). Ensure the assessor addresses all three limbs.

Step 2: For s 44 (treatment authorisation) applications, use the required clinical checklist (reg 4(3))

• The report must come from a registered health practitioner and must include the condition requiring treatment, nature and timing of proposed treatment (if known), impairment description, how impairment affects consent capacity, steps taken to provide support, whether capability may return, risks of treatment and non-treatment, whether treatment can be postponed, and available alternatives (reg 4(3)(a)-(k)).
• Have the practitioner sign and date the report and state their registration details to satisfy the “registered health practitioner” requirement.

Step 3: Avoid conflict-of-interest reporting mistakes (reg 4(6))

• Ensure the assessor is not a close family member of the person being assessed. If the would-be assessor is a family member, obtain an alternative assessor to avoid the penalty exposure.

Step 4: If a report cannot be provided, document the reasons (reg 4(5))

• If the required report cannot be procured, attach a written statement explaining why the report cannot be provided. The explanatory statement is required by the regulation and should be factual, signed and dated.

Step 5: Prepare and lodge the statutory declaration with the application (reg 5)

• The person making the application must declare that reasonable steps required by s 13 of the Act have been taken, and that the application is true, accurate, not misleading and not omitting relevant details (reg 5(1)(a)-(d)).
• Ensure the declaration is correctly executed and retained. Do not submit materially false or misleading statements; reg 5(2) creates a penalty risk.

Step 6: For oral consents, obtain written confirmation promptly (reg 13)

• If a responsible person gives consent orally under s 43, prepare and provide written confirmation to the person who received the consent as soon as practicable (reg 13).

Step 7: Advance care directives , registration and revocation requirements (regs 13C-13D)

• Who may apply: the maker, their legal representative, an adult on the maker’s behalf if requested by the maker, a guardian with health-care authority, the person responsible, or any person the Tribunal is satisfied has a proper interest (reg 13C(1)).
• Use the Tribunal-approved form for registration and attach the original written advance care directive (reg 13C(2)(a)-(b)). Confirm to the client that only the original will be accepted and that the form must be the Tribunal’s form.
• Revocation: If the directive was in writing, revoke by written indication (reg 13D(1)). If it was made other than in writing, revoke by the same method used to make it or by written indication (reg 13D(2)(a)-(b)). Keep records of revocation communications.

Step 8: For administrators providing statements of accounts, calculate “relevant estate” and pay the examination fee (reg 15)

• Determine whether the estate is a “relevant estate”: an estate over $50,000 in value at the last day of the accounting period (reg 15(1)).
• Exclude household furniture and effects, principal place of residence, a spouse’s principal residence or minor child’s principal residence, former principal place of residence meeting occupation/rental criteria, and residential aged care deposits or bonds when valuing the estate (reg 15(3)).
• If the estate is a relevant estate, pay the fee for Tribunal examination when providing the accounts: 83.5 fee units if the administrator is the Public Trustee or a trustee company, otherwise 118 fee units (reg 15(2)).
• Confirm local conversion of fee units to dollars before payment.

Step 9: Use fee-waiver process where undue hardship applies (reg 16)

• If payment of a fee will cause undue hardship to the person or someone they represent, prepare an application to the registrar under reg 16 including documentary financial evidence and a statement addressing “undue hardship.”
• File the waiver application promptly and follow up with the registrar’s office if necessary.

Step 10: Access and inspection of the register (reg 17)

• For general register inspection, attend during normal business hours; the register is to be made available to the public (reg 17(2)). For access to a registered advance care directive, ensure you are a person specified in reg 17(3) (maker, guardian with authority, person responsible, treating health practitioner, treating facility, or a person with Tribunal-satisfied proper interest).
• If you claim “proper interest” either as an applicant to register or to access a directive, be prepared to provide evidence and an argument that the Tribunal should be satisfied of your proper interest.

Step 11: Ensure organisational complaint processes comply with ISO 10002 (reg 13E)

• If you are the Public Guardian or Public Trustee, review, update and document complaints-handling policies, staff training, internal review procedures and record-keeping to align with Australian Standard 10002 (ISO 10002:2018 NEQ).

Step 12: Check related instruments and monitor external changes

• Monitor the Poisons List (Poisons Act 1971) for any changes to the schedules that will affect what counts as a restricted substance or a drug of addiction, which directly affects reg 12.
• Check the current value of a penalty unit and fee-unit conversions for accurate budgeting of fines and fees.
• Monitor public health directions under the Public Health Act 1997 that may trigger the “mandatory health care” definition in reg 13B.

Documentary checklist for an ordinary non‑s 58 application

• Tribunal application form as required by the Act.
• Supporting report from a qualified health practitioner addressing reg 4(1)(a)-(c) or reg 4(3) if s 44 application.
• Statement of reasons if a report cannot be provided (reg 4(5)).
• Declarant’s statutory declaration per reg 5(1).
• Payment or waiver application for any applicable fees (reg 14; reg 15).
• Where relevant, original advance care directive and Tribunal-approved form for registration (reg 13C(2)).
• For oral consents, contemporaneous written confirmation per reg 13.

If you want, I can convert this compliance map into a short form checklist tailored to particular roles: (a) clinician preparing s 44 reports, (b) administrator of a relevant estate preparing accounts, (c) lawyer preparing an application to register an advance care directive, or (d) a hospital clinician navigating reg 12 treatment thresholds.